Keita Harada

Medicine & Life Sciences

1. Adenoma 46%
2. AMP-Activated Protein Kinases 17%
3. C-Reactive Protein 10%
4. Case Management 22%
5. Cecum 18%
6. Colitis 15%
7. Colon 35%
8. Colonoscopy 59%
9. Colorectal Neoplasms 66%
10. Crohn Disease 45%
11. Diffuse Esophageal Spasm 11%
12. Double-Balloon Enteroscopy 14%
13. Early Detection of Cancer 20%
14. Endoscopes 17%
15. Endoscopic Mucosal Resection 100%
16. Endoscopy 9%
17. Esophageal Motility Disorders 12%
18. Estrogen Receptor alpha 11%
19. Fusobacterium nucleatum 10%
20. Hemorrhage 10%
21. Immunoturbidimetry 10%
22. Inflammatory Bowel Diseases 22%
23. Insufflation 18%
24. Interferons 13%
25. Japan 12%
26. Leukocyte L1 Antigen Complex 54%
27. Liquid Biopsy 10%
28. Lower Gastrointestinal Tract 10%
29. Methylation 31%
30. Mucous Membrane 29%
31. Multicenter Studies 19%
32. Mutation 13%
33. Myotomy 19%
34. Neoplasms 28%
35. Pathologic Constriction 17%
36. Pentazocine 10%
37. Platelet Count 20%
38. Polyps 28%
39. Polysaccharides 13%
40. Portography 10%
41. Randomized Controlled Trials 19%
42. Recurrence 33%
43. Remission Induction 13%
44. Schizophrenia 17%
45. Sigmoid Neoplasms 10%
46. Surgical Instruments 13%
47. Therapeutics 9%
48. Tomography 9%
49. Tumor Necrosis Factor-alpha 10%
50. Ulcerative Colitis 90%